SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that Medicare reimbursement for CorMedixs DefenCath could fall sharply in 2027 has fueled a steep selloff and concern about future pricing and sales. Traders dispute how conclusive DaVitas estimate is, pointing to CMSs finalized payment rate and arguing the outlook depends on quarterly calculations and DefenCath uptake.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

FDA approval of Inovios competing RRP treatment has put Precigens PAPZIMEOS under scrutiny, with traders debating whether the new option will erode its market position. Some fear stronger competition, while others point to Precigens first-mover and full-approval advantages and question Inovios ability to commercialize its drug.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons stronger-than-expected third-quarter results, supported by Eylea HD and Dupixent-related collaboration revenue, are driving a sharp breakout to multiyear highs. Traders are broadly bullish on the results and follow-through, while some question whether the gains will hold.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean is drawing attention after Brazil approved its Valaris merger, which traders see as a step toward closing the deal, alongside recent offshore contract wins and higher day-rate expectations. Bulls anticipate improved scale and a potential short squeeze, while skeptics point to merger-related dilution, debt and the upcoming earnings report.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopifys integration with Metas Muse AI agent, which can route purchases through Shop Pay, has fueled discussion about whether agentic commerce will expand Shopifys role in online shopping or threaten traditional storefronts. Traders are also debating the stocks sharp, volatile pullback, with some looking ahead to earnings and others concerned about valuation and whether AI-related growth will translate into revenue.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,942,077.7905448. The last known price of Zcash is 1,263.32437248 USD and is up 2.82 over the last 24 hours. It is currently trading on 668 active market(s) with $1,115,981,976.30 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcashs sharp rebound and resilience amid broader crypto weakness and Binance hack fears have traders highlighting its privacy features and speculating about a safe-haven shift into ZEC; some also point to the upcoming NU7 upgrade. Others view the rally as overextended and expect further declines.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

A stronger-than-expected quarterly report and higher full-year revenue outlook, powered by demand for Mounjaro and Zepbound, have fueled LLYs rally and record highs. Traders are largely positive and cite analyst upgrades, while some question the valuation and point to trimmed profit guidance tied to acquisition-related research charges.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A rally to a fresh 52-week high ahead of an expected quarterly report has traders focused on BRIUMVI growth and whether results can justify the run; some expect an earnings-driven move, while others warn the stock may be priced for a beat. Buyout speculation and possible short covering are also fueling bullish chatter, but no deal is confirmed and the earnings timing remains uncertain.

BankrCoin (BNKR) is a cryptocurrency and operates on the Base platform. BankrCoin has a current supply of 100,000,000,000 with 99,389,999,999.99966667 in circulation. The last known price of BankrCoin is 0.00029512 USD and is up 9.48 over the last 24 hours. It is currently trading on 84 active market(s) with $2,292,823.67 traded over the last 24 hours. More information can be found at https://warpcast.com/bankr.

BankrCoin

Traders are focused on Bankrs expanding AI-agent infrastructure and ecosystem integrations, alongside claims of protocol revenue, staking rewards and token buybacks that could support BNKR demand. Sentiment is largely bullish and accumulation-oriented, though some traders question whether the sharp moves are sustainable or speculative.

ExxonMobil Holdings Corp. is an international energy and petrochemical company, which creates solutions that improve quality of life and meets society’s evolving needs. The company is headquartered in Spring, TX.

ExxonMobil Holdings Corp.

Exxon Mobil Corp

Exxons quarterly results beat expectations, with record refining performance benefiting from tight diesel supplies amid geopolitical disruptions. Traders are broadly positive on the refining-led strength and shareholder returns, while some question whether the unusually strong margins can last.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cardlytics to Report Third Quarter 2026 Results on November 5

Cardlytics, Inc. (NASDAQ: CDLX) today announced that its financial results for the third quarter that ended September 30, 2026 will be released on November 5, 2026, after market close. Conference Call Details: When: November 5, 2026 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees...

Cardlytics and Rove Team Up to Help Travelers Earn Their Next Trip Faster

Cardlytics Inc. (NASDAQ: CDLX) today announced a new partnership with Rove, the first universal airline mile program built for Gen Z and Millennials, extending the Cardlytics Rewards Platform (CRP) and further diversifying Cardlytics supply footprint.Since launching in 2025, Rove has quickly grown...

Similarweb Names Michael Akkerman as New Chief Executive Officer

Similarweb Ltd. (NYSE: SMWB), a leading digital data and analytics company, today announced that its Board of Directors has appointed Michael Akkerman as Chief Executive Officer, effective November 2, 2026. Mr. Akkerman succeeds Founder and CEO Or Offer, who, as previously announced in May 2026, is...

Cardlytics (CDLX) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Cardlytics Second Quarter 2026 Financial Results Driven By Strong Operational Performance

Cardlytics, Inc. (NASDAQ: CDLX), a purchase intelligence platform, today announced financial results for the second quarter ended June 30, 2026. "The second quarter shows that our execution is translating directly into results. We were within our guidance across all key metrics, with margins...

Cardlytics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Cardlytics, Inc. (NASDAQ: CDLX) today announced that on July 29, 2026, the Compensation Committee of Cardlytics Board of Directors granted an aggregate of 10,320 restricted stock units of Cardlytics to 10 newly hired employees. The restricted stock units were granted as material inducements to...

Cardlytics Appoints Chris Cheng as Chief Legal Officer

Cardlytics Inc. (NASDAQ: CDLX) today announced the appointment of Chris Cheng as Chief Legal Officer, effective August 3, 2026. Cheng will serve on the Leadership Team and oversee Cardlytics Legal and Compliance organization. This press release features multimedia. View the full release here...

Cardlytics to Report Second Quarter 2026 Results on August 5

Cardlytics, Inc. (NASDAQ: CDLX) today announced that its financial results for the second quarter ending June 30, 2026 will be released on August 5, 2026, after market close. Conference Call Details: When: August 5, 2026 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access...

Lake Street Cuts Cardlytics, Inc. (CDLX) Price Target to $1.25 Amid Reset Expectations

Lake Street Cuts Cardlytics, Inc. (CDLX) Price Target to $1.25 Amid Reset Expectations...

Cardlytics (CDLX) Q1 2026 Earnings Transcript

Cardlytics, Inc. engages in the business of operating an advertising platform which includes online, mobile applications, email, and various real-time notifications. It operates through the Cardlytics Platform and Bridg Platform segments. The Cardlytics Platform segment focuses on the United States and the United Kingdom, which represents proprietary advertising channels. The Bridg Platform segment is involved in utilizing POS data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing in a privacy protected manner. The company was founded by Scott David Grimes, Lynne Marie Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.

Cardlytics Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Stocktwits

Stocktwits Polls

This guy called you MNDR for 400%. Insane call. Banked 5k :)  
 
Make sure to give him a FOLLOW below 🚀 
 
Looking forward to join his next pick 👀 
 
$CDLX $SPCX ls

Ludey

$CDLX Got the actual Form 4s from EDGAR. Verified numbers:

- **Oct 2 filing:** sold 10,351 shares @ $2.71 on 10/1, then 7,382 @ $2.53 on 10/2 — 138,906 shares owned after. [Filing](https://www.sec.gov/Archives/edgar/data/1666071/000162828026064668/xslF345X06/wk-form4_1790976643.xml)
- **Aug 18 filing:** sold 6,785 @ $3.97 on 8/17 and 6,676 @ $4.03 on 8/18. [Filing](https://www.sec.gov/Archives/edgar/data/1666071/000162828026057772/xslF345X06/wk-form4_1787088440.xml)
- **Jul 6 filing:** sold 6,498 @ $4.40 on 7/2 and 9,640 @ $4.39 on 7/6. [Filing](https://www.sec.gov/Archives/edgar/data/1666071/000162828026047392/xslF345X06/wk-form4_1783374763.xml)

Feed

News

Sentiment

Earnings

Fundamentals

Info

CDLX Cardlytics Inc

Fundamentals

Latest CDLX News